Pharmacovigilance (English Wikipedia)

"Navigating Emerging Markets — Latin America". Biopharminternational.com. April 1, 2013. Archived from the original on March 29, 2014. Retrieved February 27, 2015.

bnds.fr

Guerriaud, Mathieu (February 1, 2016). "Pharmacovigilance européenne, un système aux multiples visages". BNDS (in French). Retrieved July 5, 2016.

canada.ca

"Health Products and Food Branch". Government of Canada. June 25, 2018. Retrieved October 29, 2018.

cdsco.nic.in

"Central Drugs Standard Control Organization". Cdsco.nic.in. Archived from the original on April 10, 2008. Retrieved February 27, 2015.

clinicalleader.com

"China's Pharmacovigilance System: The Hunger For Safety Insights". Clinicalleader.com. December 7, 2011. Retrieved February 27, 2015.

doi.org

Mackenzie SG, Lippman A (January 1989). "An investigation of report bias in a case-control study of pregnancy outcome". American Journal of Epidemiology. 129 (1): 65–75. doi:10.1093/oxfordjournals.aje.a115125. PMID 2910073.
Lexchin J (March 2005). "Drug withdrawals from the Canadian market for safety reasons, 1963-2004". CMAJ. 172 (6): 765–7. doi:10.1503/cmaj.045021. PMC 552890. PMID 15767610.
Hoffmann E, Fouretier A, Vergne C, et al. (2012). "Pharmacovigilance Regulatory Requirements in Latin America". Pharm Med. 26 (3): 153–164. doi:10.1007/bf03262389. S2CID 206837124.
Holm G, Snape JR, Murray-Smith R, Talbot J, Taylor D, Sörme P (July 2013). "Implementing ecopharmacovigilance in practice: challenges and potential opportunities". Drug Safety. 36 (7): 533–46. doi:10.1007/s40264-013-0049-3. PMC 3691479. PMID 23620169.
Rahman SZ, Khan RA (December 2006). "Environmental pharmacology: A new discipline". Indian Journal of Pharmacology. 38 (4): 229–30. doi:10.4103/0253-7613.27017.
Ruhoy IS, Daughton CG (November 2008). "Beyond the medicine cabinet: an analysis of where and why medications accumulate". Environment International. 34 (8): 1157–69. Bibcode:2008EnInt..34.1157R. doi:10.1016/j.envint.2008.05.002. PMID 18571238.
Rahman SZ, Khan RA, Gupta V, Uddin M (July 2007). "Pharmacoenvironmentology–a component of pharmacovigilance". Environmental Health. 6 (20): 20. Bibcode:2007EnvHe...6...20R. doi:10.1186/1476-069X-6-20. PMC 1947975. PMID 17650313.
Rahman SZ (January 2019). "Concept of Materiovigilance in Unani Medicine". Bangladesh Journal of Medical Science. 18 (1): 5–6. doi:10.3329/bjms.v18i1.39539.
Sarker A, Ginn R, Nikfarjam A, O'Connor K, Smith K, Jayaraman S, et al. (April 2015). "Utilizing social media data for pharmacovigilance: A review". Journal of Biomedical Informatics. 54: 202–12. doi:10.1016/j.jbi.2015.02.004. PMC 4408239. PMID 25720841.

europa.eu

eur-lex.europa.eu

"DIRECTIVE 2010/84/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use (Text with EEA relevance)". EUR-Lex: Access to European law. Retrieved December 9, 2024.
MDR - 2017/745
IVDR - 2017/746

ema.europa.eu

"Guideline on good pharmacovigilance practices (GVP)Annex I - Definitions (Rev 4)" (PDF).
"Safety monitoring of medicines" European Medicines Agency
"Good pharmacovigilance practices". September 17, 2018.

fda.gov

"Reporting By Health Professionals". Fda.gov. Archived from the original on June 6, 2009. Retrieved February 27, 2015. This article incorporates text from this source, which is in the public domain.

forbes.com

"Why Big Pharma Won't Get Its Piece Of The $1.2 Trillion Global Drug Market". Forbes. December 7, 2012. Retrieved February 27, 2015.

globalnews.ca

Minsky, Amy (August 18, 2017). "Opposition stands behind former MP accusing Health Canada of gutting drug safety law". Global News. Retrieved October 29, 2018.

harvard.edu

ui.adsabs.harvard.edu

Ruhoy IS, Daughton CG (November 2008). "Beyond the medicine cabinet: an analysis of where and why medications accumulate". Environment International. 34 (8): 1157–69. Bibcode:2008EnInt..34.1157R. doi:10.1016/j.envint.2008.05.002. PMID 18571238.
Rahman SZ, Khan RA, Gupta V, Uddin M (July 2007). "Pharmacoenvironmentology–a component of pharmacovigilance". Environmental Health. 6 (20): 20. Bibcode:2007EnvHe...6...20R. doi:10.1186/1476-069X-6-20. PMC 1947975. PMID 17650313.

ich.org

"ICH Official web site : ICH". www.ich.org. Archived from the original on November 10, 2010.
"ICH Official web site : ICH". www.ich.org. Archived from the original on August 23, 2010.
"Organisation". ICH. Retrieved February 27, 2015.
"Steering Committee". ICH. Archived from the original on February 27, 2015. Retrieved February 27, 2015.

ipc.gov.in

"Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare, Government of India". Ipc.gov.in. Retrieved February 27, 2015.

ireminder.com

"Risk Evaluation Mitigation Strategies and ETASU programs". Ireminder.com. Archived from the original on December 26, 2010. Retrieved February 27, 2015.

isoponline.org

"ISoP : International Society of Pharmacovigilance - Home". Isoponline.org. Retrieved February 27, 2015.

medagencies.org

heads.medagencies.org

"Heads of Medicines Agencies: Home". Heads.medagencies.org. Retrieved February 27, 2015.

meddra.org

"MedDRA MSSO | MedDRA". www.meddra.org. Retrieved March 16, 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Mackenzie SG, Lippman A (January 1989). "An investigation of report bias in a case-control study of pregnancy outcome". American Journal of Epidemiology. 129 (1): 65–75. doi:10.1093/oxfordjournals.aje.a115125. PMID 2910073.
Lexchin J (March 2005). "Drug withdrawals from the Canadian market for safety reasons, 1963-2004". CMAJ. 172 (6): 765–7. doi:10.1503/cmaj.045021. PMC 552890. PMID 15767610.
Holm G, Snape JR, Murray-Smith R, Talbot J, Taylor D, Sörme P (July 2013). "Implementing ecopharmacovigilance in practice: challenges and potential opportunities". Drug Safety. 36 (7): 533–46. doi:10.1007/s40264-013-0049-3. PMC 3691479. PMID 23620169.
Ruhoy IS, Daughton CG (November 2008). "Beyond the medicine cabinet: an analysis of where and why medications accumulate". Environment International. 34 (8): 1157–69. Bibcode:2008EnInt..34.1157R. doi:10.1016/j.envint.2008.05.002. PMID 18571238.
Rahman SZ, Khan RA, Gupta V, Uddin M (July 2007). "Pharmacoenvironmentology–a component of pharmacovigilance". Environmental Health. 6 (20): 20. Bibcode:2007EnvHe...6...20R. doi:10.1186/1476-069X-6-20. PMC 1947975. PMID 17650313.
Sarker A, Ginn R, Nikfarjam A, O'Connor K, Smith K, Jayaraman S, et al. (April 2015). "Utilizing social media data for pharmacovigilance: A review". Journal of Biomedical Informatics. 54: 202–12. doi:10.1016/j.jbi.2015.02.004. PMC 4408239. PMID 25720841.

ncbi.nlm.nih.gov

Lexchin J (March 2005). "Drug withdrawals from the Canadian market for safety reasons, 1963-2004". CMAJ. 172 (6): 765–7. doi:10.1503/cmaj.045021. PMC 552890. PMID 15767610.
Holm G, Snape JR, Murray-Smith R, Talbot J, Taylor D, Sörme P (July 2013). "Implementing ecopharmacovigilance in practice: challenges and potential opportunities". Drug Safety. 36 (7): 533–46. doi:10.1007/s40264-013-0049-3. PMC 3691479. PMID 23620169.
Rahman SZ, Khan RA, Gupta V, Uddin M (July 2007). "Pharmacoenvironmentology–a component of pharmacovigilance". Environmental Health. 6 (20): 20. Bibcode:2007EnvHe...6...20R. doi:10.1186/1476-069X-6-20. PMC 1947975. PMID 17650313.
Sarker A, Ginn R, Nikfarjam A, O'Connor K, Smith K, Jayaraman S, et al. (April 2015). "Utilizing social media data for pharmacovigilance: A review". Journal of Biomedical Informatics. 54: 202–12. doi:10.1016/j.jbi.2015.02.004. PMC 4408239. PMID 25720841.

nursesunions.ca

Gagnon, Marc-André (June 2014). "A Roadmap to a Rational Pharmacare Policy" (PDF). The Canadian Federation of Nurses Unions.

paho.org

"Pan American Network for Drug Regulatory Harmonization". Paho.org. Retrieved February 27, 2015.

pharmacyboardkenya.org

pv.pharmacyboardkenya.org

"Pharmacovigilance Electronic Reporting System - Kenya". Retrieved February 27, 2015.

pharmcontrol.com

"Pharmcontrol".

se-fc.org

"Generalidades". Se-fc.org. Archived from the original on February 27, 2015. Retrieved February 27, 2015.

semanticscholar.org

api.semanticscholar.org

Hoffmann E, Fouretier A, Vergne C, et al. (2012). "Pharmacovigilance Regulatory Requirements in Latin America". Pharm Med. 26 (3): 153–164. doi:10.1007/bf03262389. S2CID 206837124.

sjpharmaco.com

"Preparing for a Safety Inspection" (PDF). Steve Jolley. 2011. Archived from the original (PDF) on January 9, 2016. Retrieved January 4, 2016.

swissmedic.ch

"GCP and Pharmacovigilance Inspections - Swissmedic". Swissmedic.ch. Archived from the original on May 8, 2014. Retrieved February 27, 2015.

uonbi.ac.ke

pharmacology.uonbi.ac.ke

"Master of Pharmacy in Pharmacoepidemiology & Pharmacovigilance". Archived from the original on August 17, 2016. Retrieved June 28, 2016.

web.archive.org

"Preparing for a Safety Inspection" (PDF). Steve Jolley. 2011. Archived from the original (PDF) on January 9, 2016. Retrieved January 4, 2016.
"ICH Official web site : ICH". www.ich.org. Archived from the original on November 10, 2010.
"ICH Official web site : ICH". www.ich.org. Archived from the original on August 23, 2010.
"Uppsala Monitoring Centre". who-umc.org. Archived from the original on June 27, 2010. Retrieved February 27, 2015.
"Risk Evaluation Mitigation Strategies and ETASU programs". Ireminder.com. Archived from the original on December 26, 2010. Retrieved February 27, 2015.
"UMC - WHO Programme". www.who-umc.org. Archived from the original on October 24, 2017. Retrieved October 24, 2017.
"UMC - Being a member". www.who-umc.org. Archived from the original on October 24, 2017. Retrieved October 24, 2017.
"Steering Committee". ICH. Archived from the original on February 27, 2015. Retrieved February 27, 2015.
"The Importance of Pharmacovigilance - Safety Monitoring of Medicinal Products: Chapter 2 - A Short History of Involvement in Drug Safety Monitoring by WHO". Apps.who.int. February 10, 2015. Archived from the original on March 11, 2012. Retrieved February 27, 2015.
"Master of Pharmacy in Pharmacoepidemiology & Pharmacovigilance". Archived from the original on August 17, 2016. Retrieved June 28, 2016.
"Navigating Emerging Markets — Latin America". Biopharminternational.com. April 1, 2013. Archived from the original on March 29, 2014. Retrieved February 27, 2015.
"Central Drugs Standard Control Organization". Cdsco.nic.in. Archived from the original on April 10, 2008. Retrieved February 27, 2015.
"Generalidades". Se-fc.org. Archived from the original on February 27, 2015. Retrieved February 27, 2015.
"GCP and Pharmacovigilance Inspections - Swissmedic". Swissmedic.ch. Archived from the original on May 8, 2014. Retrieved February 27, 2015.
"Reporting By Health Professionals". Fda.gov. Archived from the original on June 6, 2009. Retrieved February 27, 2015. This article incorporates text from this source, which is in the public domain.

who-umc.org

"International Drug Monitoring : The Role of National Centers" (PDF). Who-umc.org. Retrieved February 27, 2015.
"Uppsala Monitoring Centre". who-umc.org. Archived from the original on June 27, 2010. Retrieved February 27, 2015.
"UMC - WHO Programme". www.who-umc.org. Archived from the original on October 24, 2017. Retrieved October 24, 2017.
"UMC - Being a member". www.who-umc.org. Archived from the original on October 24, 2017. Retrieved October 24, 2017.

who.int

apps.who.int

The Importance of Pharmacovigilance (Report). World Health Organization. 2002. ISBN 9-241-59015-7. Retrieved December 31, 2020.
"The Importance of Pharmacovigilance - Safety Monitoring of Medicinal Products: Chapter 2 - A Short History of Involvement in Drug Safety Monitoring by WHO". Apps.who.int. February 10, 2015. Archived from the original on March 11, 2012. Retrieved February 27, 2015.

worldcat.org

search.worldcat.org

Council for International Organizations of Medical Sciences. Working Group VIII. (2010). Practical aspects of signal detection in pharmacovigilance : report of CIOMS Working Group VIII. CIOMS. ISBN 978-92-9036-082-7. OCLC 676726220.